This significant decrease is attributable to the termination of the sale of the fibrin sealant Hemaseel APR in November 2003.
This decrease was attributable to a declining sale price of Hemaseel APR and the absence of commission revenues from the sale of Gelfoam.
This decrease is mainly due to the decrease in trade accounts receivable and inventories, as a result of the termination of the sale of Hemaseel APR, and to the decrease in other receivables resulting from the cashing in November 2003 and January 2004 of amounts to be received from Baxter Healthcare S.A.
Hemaseel APR consists of two blood proteins, fibrinogen and thrombin, which form a mesh-like structure when mixed.
"Multiple hospitals and surgeons have used Hemaseel APR for trauma surgery, cardiopulmonary surgery and other indications," says Paquin.
This facility separates plasma proteins necessary for the production of Hemaseel APR and HMN.